These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35323478)

  • 1. Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study.
    ElNaggar MH; Abdelwahab GM; Kutkat O; GabAllah M; Ali MA; El-Metwally MEA; Sayed AM; Abdelmohsen UR; Khalil AT
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
    Bafna K; White K; Harish B; Rosales R; Ramelot TA; Acton TB; Moreno E; Kehrer T; Miorin L; Royer CA; García-Sastre A; Krug RM; Montelione GT
    Cell Rep; 2021 May; 35(7):109133. PubMed ID: 33984267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors.
    Freire MCLC; Noske GD; Bitencourt NV; Sanches PRS; Santos-Filho NA; Gawriljuk VO; de Souza EP; Nogueira VHR; de Godoy MO; Nakamura AM; Fernandes RS; Godoy AS; Juliano MA; Peres BM; Barbosa CG; Moraes CB; Freitas-Junior LHG; Cilli EM; Guido RVC; Oliva G
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from
    Al-Karmalawy AA; Alnajjar R; Elmaaty AA; Binjubair FA; Al-Rashood ST; Mansour BS; Elkamhawy A; Eldehna WM; Mansour KA
    J Biomol Struct Dyn; 2024 Aug; 42(13):6941-6953. PubMed ID: 37505066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of novel and highly selective SARS-CoV-2 main protease inhibitors.
    Poli ANR; Tietjen I; Nandwana NK; Cassel J; Messick TE; Register ET; Keeney F; Rajaiah R; Verma AK; Pandey K; Acharya A; Byrareddy SN; Montaner LJ; Salvino JM
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0056224. PubMed ID: 39225484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
    Pirzada RH; Haseeb M; Batool M; Kim M; Choi S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
    Jung LS; Gund TM; Narayan M
    Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.
    Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J
    ACS Infect Dis; 2021 Mar; 7(3):586-597. PubMed ID: 33645977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors.
    Ghosh AK; Shahabi D; Yadav M; Kovela S; Anson BJ; Lendy EK; Bonham C; Sirohi D; Brito-Sierra CA; Hattori SI; Kuhn R; Mitsuya H; Mesecar AD
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library.
    Lee JY; Kuo CJ; Shin JS; Jung E; Liang PH; Jung YS
    Bioorg Med Chem Lett; 2021 Jun; 42():128067. PubMed ID: 33957246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
    Choudhury M; Dhanabalan AK; Goswami N
    J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs.
    Panagiotopoulos AA; Karakasiliotis I; Kotzampasi DM; Dimitriou M; Sourvinos G; Kampa M; Pirintsos S; Castanas E; Daskalakis V
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of Specific Fluoroquinolone Interaction with SARS-CoV-2 Main Protease (Mpro) to Battle COVID-19: DFT, Molecular Docking, ADME and Cardiotoxicity Studies.
    Khan MA; Mutahir S; Tariq MA; Almehizia AA
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents.
    Maikhunthod B; Chaipayang S; Jittmittraphap A; Thippornchai N; Boonchuen P; Tittabutr P; Eumkeb G; Sabuakham S; Rungrotmongkol T; Mahalapbutr P; Leaungwutiwong P; Teaumroong N; Tanthanuch W
    BMC Complement Med Ther; 2024 Jul; 24(1):274. PubMed ID: 39030504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of M
    Altomare A; Baron G; Cambiaghi G; Ferrario G; Zoanni B; Della Vedova L; Fumagalli GM; D'Alessandro S; Parapini S; Vittorio S; Vistoli G; Riso P; Carini M; Delbue S; Aldini G
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893578
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
    J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.
    Szemiel AM; Merits A; Orton RJ; MacLean OA; Pinto RM; Wickenhagen A; Lieber G; Turnbull ML; Wang S; Furnon W; Suarez NM; Mair D; da Silva Filipe A; Willett BJ; Wilson SJ; Patel AH; Thomson EC; Palmarini M; Kohl A; Stewart ME
    PLoS Pathog; 2021 Sep; 17(9):e1009929. PubMed ID: 34534263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study.
    Abdelaal Ahmed Mahmoud M Alkhatip A; Georgakis M; Montero Valenzuela LR; Hamza M; Farag E; Hodgkinson J; Hosny H; Kamal AM; Wagih M; Naguib A; Yassin H; Algameel H; Elayashy M; Abdelhaq M; Younis MI; Mohamed H; Abdulshafi M; Elramely MA
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.